Allergy and Immunology

Daily Living and Long-Term Monitoring

At a Glance

People with PLCG2-associated disease need individualized follow-up rather than a fixed testing schedule. Avoid cold-water immersion, plan for emergency epinephrine when indicated, and monitor the lungs, eyes, immune system, and warning symptoms with a specialist.

Living with a PLCG2-associated disease requires a shift in perspective. Because these conditions are ultra-rare and unpredictable, daily life is often defined by “vigilance without panic.” By establishing clear safety protocols and a consistent monitoring schedule, you can regain a sense of control over the diagnosis.

Daily Safety: Managing the Cold in PLAID

For those with PLAID, the primary daily challenge is preventing the PLCγ2 enzyme from overreacting in response to cooling. This requires more than just wearing a coat in winter; it involves managing subtle temperature shifts.

Evaporative Cooling: The enzyme is often triggered as moisture evaporates from the skin. This means that sweat cooling on the skin after exercise, or the air hitting damp skin after a bath, can trigger hives just as easily as a blast of winter air ^[1]^[2].
The Swimming Rule: Full-body immersion in cold water (pools, lakes, or the ocean) is the highest-risk activity for cold-induced anaphylaxis ^[3]. You should completely avoid unheated cold-water immersion unless your treating specialist has provided explicit clearance, and never swim alone. Note that a localized “cold-stimulation test” (like an ice cube test) cannot guarantee that full-body swimming is safe, and a negative test does not mean you are cleared to swim ^[4].
The Epi-Pen: If you have a history of systemic reactions, you must always have an epinephrine autoinjector within reach. Ensure that family, teachers, and coworkers know how to use it and understand that cold exposure is a medical trigger for you ^[3].

Long-Term Monitoring: The Surveillance Schedule

There is no “one-size-fits-all” or validated schedule for PLCG2 diseases. Instead, your medical team will create a highly individualized plan based on your specific symptoms, extrapolated from similar immune conditions ^[5]^[6]. Routine HRCT, MRI/MRA, or pulmonary-vein imaging is not established for all patients.

Lung Health

Recurrent infections can lead to bronchiectasis (permanent scarring of the airways) or interstitial lung disease (inflammation of the lung tissue) ^[7]^[8].

Pulmonary Function Tests (PFTs): These breathing tests may be used to monitor how well the lungs are moving air (in older patients who can reliably perform them) ^[6]^[9].
Imaging: A High-Resolution CT (HRCT) scan may be used as a baseline, but because of radiation concerns, these are not usually repeated on a fixed schedule unless driven by symptoms like a chronic cough ^[10]^[11].

Eye and Brain Health

Ophthalmology: Because uveitis and corneal pannus (abnormal blood vessel growth) can be painless in the early stages, routine eye exams are essential. A baseline surveillance schedule is useful, but active eye disease requires much more frequent, specialist-driven checks ^[12]^[13].
Neurologic and Vascular Checks: In APLAID, doctors watch for signs of vasculitis (blood vessel inflammation) or pulmonary vein stenosis (narrowing of the veins in the lungs). This involves monitoring for new seizures, severe headaches, or sudden changes in breathing ^[14]^[15].

The Psychological Toll

Managing an ultra-rare disease is emotionally exhausting. Patients and parents often face:

Scan Anxiety: Stress leading up to routine monitoring appointments.
Hyper-vigilance: A constant, draining fear of accidental cold exposure or the next inflammatory flare ^[16].
Isolation: The feeling that no one—including many doctors—understands the condition.

Research in related immune disorders shows that these conditions significantly impact Health-Related Quality of Life ^[17]^[18]. It is not a sign of weakness to seek help from a therapist or counselor who specializes in chronic illness. Tools like shared decision-making, where you and your doctor weigh the burdens of treatment against the benefits, can help reduce the feeling of being overwhelmed by medical demands ^[19].

Monitoring Area	What is Checked	Illustrative Specialist-Tailored Framework
Immune System	Antibody levels (IgG/A/M) and B-cell counts	Extrapolated 3-6 mos (depends on history)
Lungs	PFTs (if old enough) and physical exam	Extrapolated 6-12 mos or symptom-driven
Eyes	Screening for uveitis and corneal health	Baseline, then guided by ophthalmologist
Vascular	Blood pressure and symptom review	Symptom-driven, not routine for all
Growth/Neuro	Developmental milestones (children)	Every visit

Common questions in this guide

Why can sweating or damp skin trigger hives in PLAID?

In PLAID, changes in skin temperature can activate the altered PLCγ2 pathway. Cooling as sweat or bath water evaporates, or when air hits damp skin, may trigger hives even without extreme cold.

Is swimming in cold water safe for someone with PLAID?

Full-body immersion in cold water carries a high risk of a severe systemic reaction, including cold-induced anaphylaxis. Avoid unheated cold-water swimming unless the treating specialist gives explicit clearance, and never swim alone; an ice-cube or other localized cold test cannot prove that swimming is safe.

What should families know about using an epinephrine autoinjector?

People with a history of systemic reactions should keep an epinephrine autoinjector within reach. Family members, teachers, and coworkers should know the person’s cold-exposure trigger and be trained to use the device in an emergency.

How often should PLCG2-associated disease be monitored?

There is no single validated schedule for PLCG2-associated diseases, so the medical team sets monitoring based on symptoms and history. Follow-up may include antibody and B-cell testing, lung assessments, and eye exams, while imaging is generally guided by baseline findings or symptoms rather than a fixed schedule.

What lung and eye tests may be used during follow-up?

Pulmonary function tests may monitor breathing in people old enough to perform them reliably, and a high-resolution CT may be considered as a baseline or for symptoms such as chronic cough. Eye exams can screen for uveitis and corneal pannus; active eye disease usually requires more frequent visits directed by an ophthalmologist.

What warning signs should be tracked in APLAID?

New seizures, severe headaches, or sudden changes in breathing should be reported promptly because doctors monitor for vascular or neurologic problems such as vasculitis and pulmonary vein stenosis. The treating team can explain which symptoms require emergency care for the individual patient.

What mental health support can help with PLCG2-associated disease?

Scan anxiety, hypervigilance, and isolation can add to the burden of an ultra-rare disease. A therapist or counselor familiar with chronic illness, along with shared decision-making with the medical team, may help patients and caregivers manage stress.

Get notified when new evidence is published on PLCG2-associated antibody deficiency and immune dysregulation.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (19)

1
Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With PLCG2 Mutations.
Aderibigbe OM, Priel DL, Lee CC, et al.
JAMA dermatology 2015; (151(6)):627-34 doi:10.1001/jamadermatol.2014.5641.
PMID: 25760457
2
Cool-temperature-mediated activation of phospholipase C-γ2 in the human hereditary disease PLAID.
Schade A, Walliser C, Wist M, et al.
Cellular signalling 2016; (28(9)):1237-1251 doi:10.1016/j.cellsig.2016.05.010.
PMID: 27196803
3
Cold-induced Anaphylaxis: The Case of a 9-year-old Child and Review of the Literature.
Romita P, Mascia P, Calogiuri G, Foti C
Endocrine, metabolic & immune disorders drug targets 2017; (17(2)):96-99 doi:10.2174/1871530317666170703122939.
PMID: 28675997
4
Cold-Induced Urticarias with Familial Background: Clinical Spectrum, Pathogenesis, and Diagnostic Challenges.
Zhou N, Zhi Y
Diagnostics (Basel, Switzerland) 2025; (15(24)) doi:10.3390/diagnostics15243195.
PMID: 41464195
5
Treatment and management of primary antibody deficiency: German interdisciplinary evidence-based consensus guideline.
Hanitsch L, Baumann U, Boztug K, et al.
European journal of immunology 2020; (50(10)):1432-1446 doi:10.1002/eji.202048713.
PMID: 32845010
6
Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group.
Jolles S, Sánchez-Ramón S, Quinti I, et al.
Clinical and experimental immunology 2017; (190(2)):226-234 doi:10.1111/cei.13012.
PMID: 28708268
7
Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach.
Pecoraro A, Crescenzi L, Granata F, et al.
International immunopharmacology 2017; (52()):136-142 doi:10.1016/j.intimp.2017.09.005.
PMID: 28898770
8
Lung Disease in Primary Antibody Deficiencies.
Schussler E, Beasley MB, Maglione PJ
The journal of allergy and clinical immunology. In practice 2016; (4(6)):1039-1052 doi:10.1016/j.jaip.2016.08.005.
PMID: 27836055
9
Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review.
Lamers OAC, Smits BM, Leavis HL, et al.
Frontiers in immunology 2021; (12()):606099 doi:10.3389/fimmu.2021.606099.
PMID: 33936030
10
Diagnostic testing for interstitial lung disease in common variable immunodeficiency: a systematic review.
Bintalib HM, van de Ven A, Jacob J, et al.
Frontiers in immunology 2023; (14()):1190235 doi:10.3389/fimmu.2023.1190235.
PMID: 37223103
11
Pulmonary surveillance in inborn errors of immunity: current challenges and emerging approaches.
Hoptioncann E, Eddy RL, Biggs CM, Rayment JH
Frontiers in immunology 2026; (17()):1797843 doi:10.3389/fimmu.2026.1797843.
PMID: 42245666
12
Ocular involvement in monogenic autoinflammatory disease.
Maccora I, Marrani E, Mastrolia MV, et al.
Autoimmunity reviews 2021; (20(11)):102944 doi:10.1016/j.autrev.2021.102944.
PMID: 34509650
13
Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study.
Fonollosa A, Pelegrín L, García-Morillo S, et al.
Clinical and experimental rheumatology 2023; (41(10)):2105-2114 doi:10.55563/clinexprheumatol/ukegcc.
PMID: 37812477
14
Neurological manifestations and vasculopathy in PLCG2-associated antibody deficiency and immune dysregulation (APLAID): a case series.
Asna Ashari K, MacRae R, Hoytema van Konijnenburg DP, et al.
Pediatric rheumatology online journal 2026; (24(1)).
PMID: 42902271
15
Expanding the clinical features of autoinflammation and phospholipase Cγ2-associated antibody deficiency and immune dysregulation by description of a novel patient.
Morán-Villaseñor E, Saez-de-Ocariz M, Torrelo A, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(12)):2334-2339 doi:10.1111/jdv.15918.
PMID: 31465591
16
Provider Perceptions of Quality of Life, Neurocognition, Physical Well-being, and Psychosocial Health in Patients with Primary Immunodeficiency/Immune Dysregulation Conditions.
Michniacki TF, Walkovich KJ, Merz LE, et al.
Journal of clinical immunology 2019; (39(8)):805-813 doi:10.1007/s10875-019-00703-7.
PMID: 31655959
17
Multidimensional Assessment of Patient-Reported-Outcomes in a Multicenter Cohort of Inborn Errors of Immunity.
Yorgun Altunbas M, Sefer AP, Bilgic-Eltan S, et al.
Journal of clinical immunology 2026; (46(1)):18 doi:10.1007/s10875-025-01972-1.
PMID: 41493669
18
Patient-reported outcomes in patients with primary immunodeficiency diseases in Japan: baseline results from a prospective observational study.
Kanegane H, Ishimura M, Kawai T, et al.
Frontiers in immunology 2023; (14()):1244250 doi:10.3389/fimmu.2023.1244250.
PMID: 37828988
19
Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.
Lawrence MG, Kim VHD, Orange JS, Scherzer R
The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.
PMID: 42447994

This page is for informational purposes only and does not constitute medical advice. Your treating immunology team should tailor emergency plans and monitoring to your symptoms and health history.